Share this
Kyverna Therapeutics Closes $85 Million Series B
Five Prime Therapeutics Agrees to Sell to Amgen for $1.9 Billion
Ovid - $75 Million IPO
ALX Oncology – $186 Million IPO
Vir Biotechnology - $143 Million IPO
Applied Therapeutics $40 Million IPO
Immune Design Sale to Merck for $300 Million
Harpoon Therapeutics - $76 Million IPO
Kezar Life Sciences – $86 Million IPO